Article
Clinical non-effectiveness of clopidogrel use for peripheral artery disease in patients with CYP2C19 polymorphisms: a systematic review.
European journal of clinical pharmacology - 1 Aug 2022
Huang Shu, Yang Seonkyeong, Ly Shirly, Yoo Ryan H, Lo-Ciganic Wei-Hsuan, Eadon Michael T, Schleyer Titus, Whipple Elizabeth, Nguyen Khoa Anh
Abstract excerpt
PURPOSE: To conduct a systematic review to identify studies that assessed the association between CYP2C19 polymorphisms and clinical outcomes in peripheral artery disease (PAD) patients who took clopidogrel. METHODS: We systematically searched Ovid EMBASE, PubMed, and Web of Science from November 1997 (inception) to September 2020. We included observational studies evaluating how CYP2C19 polymorphism is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
